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Introduction:  
The prion diseases form a group of fatal neurodegenerative diseases, also described as transmissible spongiform encephalopathies (TSEs), which are caused 
by abnormal conformational isomers (PrPSc) of the host-encoded prion proteins (PrPc) (1). The mechanism by which prions elicit brain damage and the 
relative contributions of PrPSc accumulation and PrPc depletion to the prion replication remains unclear. Consequently, different animal models were created 
in order to study the role of the PrPc. Among these models, knockout mouse models were crucial in elucidating the precursor-product relationship between 
PrPc and PrPSc. On histologic analysis of tissue, spongiform degeneration and astrocytic gliosis was observed in mice lacking of prion protein (2). In vivo 1H 
MRS allows non invasive characterization of brain metabolism and it has been used to study brain metabolites changes in a wide range of neurodegenerative 
diseases. Only a very few reports describing the use of in vivo 1H MRS in prion disease have been published so far (3-5), reporting only a few metabolites 
(mainly NAA). From our knowledge, no in vivo MRS study was performed until now in mice lacking prion protein (Prnp -/-). Therefore the aim of our study 
was to use in vivo high-resolution 1H MRS at 14.1T to measure the neurochemical profile in Prnp -/- mice.  
Methods: 
Mice lacking prion protein (Prnp -/- mice) were created as described in ref (6).1H spectra were measured on 11 mice (4 Prnp -/- (16months old), 4 Prnp -/- (8 
months old) and 3 wild type (16 months old)). Anesthesia was maintained at 1.3 ± 0.2 % of isoflurane in oxygen, body temperature was kept at 36.5 ± 0.2 °C. 
All data were acquired on a 14.1T/26cm system (Varian/Magnex Scientific) using: a home-built 14 mmx21 mm quadrature coil as RF transceiver and the 
ultra-short-echo time SPECIAL spectroscopy sequence (TE=2.8ms, TR=4s, 400 scans) (7) shimmed using FASTMAP. A VOI having the size of 
1.3mm×2mm ×2.2mm was selected in the hippocampus. After first and second order shimming, the typical linewidth of water resonance at TE=2.8 ms was 
18-23 Hz. Metabolite concentrations were estimated using LCModel (8), combined with a simulated basis-set of metabolites and the spectrum of 
macromolecules measured in vivo. Absolute metabolite concentrations were obtained using the unsuppressed water signal as a reference. 
Results and Discussion: 
Fig. 1a presents coronal views of a Prnp-/- mouse brain indicating the VOI. No differences in signal intensity on theT2 weighted images were observed 
between the wild type and Prnp -/- animals. In general, spectra exhibited excellent signal-to-noise ratio (Fig. 1b and c) and notable differences in metabolite 
signals between the wild type and Prnp -/- mice were discernable (Fig. 1c), such as Ins, Gln, NAA. In the knockout mice the overall neurochemical profile 
was similar to the wild-type, with the exception of Ins which was significantly increased (~30% with p=0.03) (Fig. 2). In addition Glu, Gln, NAA showed a 
trend of decrease (~15-30%) in the Prnp -/- mice (Fig. 2). Between the two Prnp -/- groups consistent increase in Ins and decrease of Gln, Glu and NAA were 
observed. Even if Gln showed an interesting trend of decrease, visually observed also in the spectra, it remains to be solidified with increasing the number of 
wild type animals. 
In contrast to all previous studies performed on humans or mice models injected with CJD or scrapie agent (ME7 strain) (4-5), we have evaluated for the first 
time the in vivo concentration of 18 metabolites in the hippocampus of Prnp -/- mice. The increase of Ins and the trend towards a decrease in Gln detected 
may reflect gliosis, consistent with the histological features reported by ref (2) in mice lacking of prion protein, whereas the reduced NAA, Gln and Glu seem 
to indicate a dysfunction in the neurotransmitter metabolism.  
In conclusion, high-field MR spectroscopy is capable of detecting changes in brain metabolism of Prnp-/- mice compared with the wild type animals 
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Fig. 2: Neurochemical profile (mean ± SEM) in the hippocampus of wild type and Prnp -/ mice. 
Fig 1: a) A coronal views of a Prnp-/- mouse brain indicating the VOI; b) and c)SPECIAL 1H spectra (TE=2.8 ms, 
VOI = 5.7 μl, 400 scans) acquired in the hippocampus of a wild type and a Prnp -/- mouse, respectively. 
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